日本語English简体中文 繁體中文

Japan Stock of the Day – Nov 17, 2026: Kissei Pharmaceutical <4547>

Tuesday, November 17, 2026

On November 17, 2026, the most talked-about Japanese stock online was Kissei Pharmaceutical <4547>.
Background: Kissei Pharmaceutical closed at 4,400 yen, up 490 yen (12.53%), making it the top gainer on the Tokyo Stock Exchange Prime Market. While the Nikkei Stock Average fell 801 yen with semiconductor stocks leading the decline, the stock bucked the trend, rising sharply for a fourth straight day and closing at its high. The catalyst was the Phase 3 trial results for the drug candidate Creto in non-muscle-invasive bladder cancer, announced the previous day by its partner, U.S.-based CG Oncology. The results were seen as positive, and CG Oncology's shares also jumped at one point. Kissei is entitled to royalties on Creto's overseas sales, and buying gathered on expectations of a future contribution to earnings. The opening price was 4,040 yen and trading volume was 544,200 shares. Market capitalization is about 204.8 billion yen, and the year-to-date high is 5,040 yen set on February 27.

Kissei Pharmaceutical (4547)

Latest close (11/17): ¥4,400 (+490, +12.53%)

Discussion board for Kissei Pharmaceutical (Japanese)

Written by , an individual investor in Japanese stocks since 2007 (profile in Japanese).

← Previous day (Nov 16)

All posts this month

Other blogs on the same day